Joint pain is not listed as a common side effect of Ozempic. The FDA prescribing information identifies nausea, vomiting, diarrhea, abdominal pain, and constipation as the most frequent adverse reactions, reported in 5% or more of patients during clinical trials. Arthralgia (the medical term for joint pain) does not appear in the adverse reactions section at all. That said, some people do report joint discomfort while taking Ozempic, and there are a few reasons why.
What the Clinical Data Shows
In the large clinical trials that led to Ozempic’s approval, joint pain was not flagged as a side effect significant enough to include in the prescribing label. The gastrointestinal effects dominate: nausea alone affects a substantial portion of users, especially during the dose-escalation period. Joint-related complaints did not reach the threshold for inclusion.
Post-marketing surveillance tells a slightly different story. The FDA’s adverse event reporting system (FAERS) has logged reports of musculoskeletal and connective tissue problems in people taking semaglutide, the active ingredient in Ozempic. An analysis of FAERS data from 2018 through mid-2023 found a statistically notable signal for musculoskeletal complaints, meaning these reports came in at a higher-than-expected rate compared to other drugs. However, adverse event reports are voluntary and don’t prove the drug caused the symptom. People taking Ozempic often have type 2 diabetes or obesity, both of which independently raise the risk of joint problems.
Semaglutide Tends to Reduce Inflammation
If anything, the biological evidence suggests semaglutide should help joints rather than hurt them. The drug belongs to a class called GLP-1 receptor agonists, and these receptors exist not just in the gut and pancreas but also in joint tissue. Researchers have identified GLP-1 receptors on cartilage cells and the synovial membrane that lines the knee joint, which means the drug can interact directly with joint structures.
In lab and animal studies, GLP-1 receptor agonists reduced the activity of inflammatory molecules that drive cartilage breakdown and joint swelling. They also slowed the production of enzymes responsible for degrading collagen and other structural proteins in cartilage. In the broader body, semaglutide lowers C-reactive protein (CRP), a key marker of systemic inflammation. Across three large trials (the STEP program), semaglutide at a 2.4 mg weekly dose reduced CRP by 39% to 48% compared to placebo over 68 weeks. These reductions tracked alongside weight loss and were consistent regardless of starting weight or blood sugar status.
So the drug itself appears to be anti-inflammatory. This makes it unlikely that semaglutide directly triggers joint pain through some pharmacological mechanism.
Why Some People Still Get Joint Pain
The more plausible explanation for joint discomfort on Ozempic involves what happens to your body during rapid weight loss. When you lose weight quickly, you don’t just lose fat. A significant portion of the weight lost can come from muscle, a phenomenon sometimes called “Ozempic muscle.” This loss of lean mass matters for your joints because muscles act as shock absorbers and stabilizers. When they weaken or shrink, your joints bear more of the mechanical load during everyday movement.
Research on sarcopenia (the clinical term for significant muscle loss) shows a clear connection to joint pain. In studies of postmenopausal women, those with sarcopenia had notably higher rates of knee pain and radiographic knee osteoarthritis compared to those who maintained their muscle mass. The combination of sarcopenia with residual excess weight was even worse: about 39% reported knee pain compared to roughly 28% of those with sarcopenia alone.
This is relevant because many Ozempic users lose weight rapidly, sometimes 15% or more of their body weight, and without resistance exercise, a meaningful share of that loss comes from muscle. The joints that were previously supported by stronger muscles and cushioned by a body adapted to a heavier load can start to ache as the balance shifts.
Other Contributing Factors
Dehydration is another possibility. The nausea, vomiting, and reduced appetite that commonly accompany Ozempic can lead to lower fluid intake. Joints depend on adequate hydration for the synovial fluid that lubricates them, and even mild chronic dehydration can make existing joint stiffness feel worse.
There’s also a timing consideration. Many people starting Ozempic become more physically active as they lose weight and feel more energetic. Joints that have been relatively sedentary may protest when suddenly asked to do more, particularly if the supporting muscles haven’t caught up. This is garden-variety overuse discomfort rather than a drug side effect, but it’s easy to attribute to the medication you just started.
What You Can Do About It
If you’re experiencing joint pain while taking Ozempic, the most effective countermeasure is strength training. Resistance exercise preserves lean muscle mass during weight loss, which keeps your joints better supported. Even two to three sessions per week focusing on major muscle groups can make a meaningful difference. This is not just general wellness advice: it directly addresses the most likely mechanism behind the discomfort.
Staying well-hydrated matters too, especially if you’re eating less or dealing with nausea. Adequate protein intake (many clinicians suggest prioritizing protein at every meal during GLP-1 therapy) supports muscle preservation alongside exercise. If joint pain is severe, persistent, or accompanied by swelling or redness, that warrants a conversation with your prescriber to rule out unrelated conditions like gout or autoimmune arthritis, which can emerge independently at any time.
The short answer: Ozempic itself is unlikely to be directly causing your joint pain. But the rapid body composition changes it produces, particularly muscle loss, can absolutely contribute to joint discomfort in ways that are manageable with the right approach.